| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |